Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (NICE technology appraisal guidance 90).
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21378012.
- Also identified by DOI 10.1136/hrt.2010.219717.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The National Institute for Health and Clinical Excellence has recently published an update of technology appraisal guidance 90, first published in 2005, which evaluated the use of clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events. This article considers the update in detail and discusses the implications for clinical practice.
Medical subject headings
- Dipyridamole
- Platelet Aggregation Inhibitors
- Ticlopidine
- Vascular Diseases